魏勇军，博士，郑州大学药学院副教授/博导，河南省优青，河南省青年科技奖、河南省科学技术进步二等奖获得者。2008年本科毕业于陕西师范大学生物学基地班；2014年博士毕业于中国科学院上海生命科学研究院；2014年-2016年，瑞典查尔莫斯理工大学博士后；2017-2018年就职于中国科学院上海生命科学研究院中科院合成生物学重点实验室；2018-至今就职于郑州大学。
研究方向：1、利用合成生物学方法，在微生物中高效合成中草药活性分子、油脂等；2、解析人体微生物组，挖掘益生菌益生元，个性化精准调控微生物菌群。
担任河南省中兽药发酵制剂工程技术中心主任；主持国自然面上、国际（地区）合作与交流项目、青年基金等3项国自然在内的10多项横向和纵向项目。已发表论文95篇，其中，以一作/通讯（含共）在Trends in Biotechnology、Green Chemistry、《中国科学：生命科学》、《合成生物学》等期刊发表论文70篇，他引2600余次，H因子28。以第一主编出版2本Elsevier出版社合成生物学书籍，共同主编英文著作3本；参编中英文著作2部。
目前，担任BMC Microbiology、Cell旗下Heliyon、BMC Biotechnology等5本国际SCI期刊编委。担任国产高水平英文期刊The Innovation、iMeta、Eco-Environment & Health的青年编委和Gene & Protein in Disease编委。担任Discover Biotechnology、Biomolecules、Frontiers in Microbiology等10多本国际期刊的审稿编委、专刊主编或客座副主编。
担任Nature Communication等60多家高水平SCI 杂志的审稿人；参加国际微生物学会（Applied Microbiology International）研究基金等多项项目评审。
指导国家级大学生创新创业训练项目等10多项本科生科研项目；指导本科生获得全国大学生化妆品创新大赛一等奖等10多项奖项。
已获批美国、德国、日本等11 项国际专利在内的23项授权专利；在审国内外专利16项。
担任国际应用微生物学会干净水科学咨询委员会委员（Applied Microbiology International, Clean Water Scientific Advisory Group Member）、河南省微生物学会理事、北京生物饲料产业技术创新战略联盟技术专家委员会委员等。担任热心肠智库专家和多家生物技术公司研发科学家。
联系方式：yongjunwei@zzu.edu.cn
I am currently working as an Associate Professor at the School of Pharmaceutical Sciences and Laboratory of Synthetic Biology, Zhengzhou University, China. My research interests revolve around understanding the human microbiome and synthetic microbiology, with a focus on applying microbiota and synthetic biology in addressing human health issues.
I received my bachelor's degree from Shaanxi Normal University and Ph.D. degree from the Shanghai Institute for Plant Physiology and Ecology, Chinese Academy of Sciences (CAS) from 2010 to 2014. Following that, I worked as a post-doctoral researcher at Jens Nielsen’s lab at Chalmers University of Technology in Sweden from 2014 to 2016. In 2017, I served as an Assistant Professor at the Plant Physiology and Ecology department of the Chinese Academy of Sciences before joining Zhengzhou University in 2018.
To date, I have published more than 95 papers with over 2600 citations (Google Scholar h-index: 28). Some of these papers focus on human and environmental sustainability using microbiome and synthetic biology approaches. My primary research strategy entails the development of microbiome and metagenomic methods to gain insights into the diversity, novelty, and distribution of human microbiota and various environments. Additionally, I also work on producing bioactive natural products through engineered or synthetic microbes.
I currently serve as an editorial board member for BMC Microbiology, BMC Biotechnology, Journal of Applied Microbiology, and Letters in Applied Microbiology. Furthermore, I have organized 11 research topics for other journals and have reviewed numerous articles for over 45 different journals, including Nature Communications and ACS Synthetic Biology.
